228 related articles for article (PubMed ID: 22993248)
1. Regulation of endothelial MAPK/ERK signalling and capillary morphogenesis by low-amplitude electric field.
Sheikh AQ; Taghian T; Hemingway B; Cho H; Kogan AB; Narmoneva DA
J R Soc Interface; 2013 Jan; 10(78):20120548. PubMed ID: 22993248
[TBL] [Abstract][Full Text] [Related]
2. A novel vasculo-angiogenic effect of cilostazol mediated by cross-talk between multiple signalling pathways including the ERK/p38 MAPK signalling transduction cascade.
Chao TH; Tseng SY; Li YH; Liu PY; Cho CL; Shi GY; Wu HL; Chen JH
Clin Sci (Lond); 2012 Aug; 123(3):147-59. PubMed ID: 22339730
[TBL] [Abstract][Full Text] [Related]
3. Regulation of endothelial cell activation and angiogenesis by injectable peptide nanofibers.
Cho H; Balaji S; Sheikh AQ; Hurley JR; Tian YF; Collier JH; Crombleholme TM; Narmoneva DA
Acta Biomater; 2012 Jan; 8(1):154-64. PubMed ID: 21925628
[TBL] [Abstract][Full Text] [Related]
4. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
5. The angiogenic regulator CD13/APN is a transcriptional target of Ras signaling pathways in endothelial morphogenesis.
Bhagwat SV; Petrovic N; Okamoto Y; Shapiro LH
Blood; 2003 Mar; 101(5):1818-26. PubMed ID: 12406907
[TBL] [Abstract][Full Text] [Related]
6. Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways.
Lee SJ; Namkoong S; Kim YM; Kim CK; Lee H; Ha KS; Chung HT; Kwon YG; Kim YM
Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2836-46. PubMed ID: 16877565
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 protects endothelial cells against gamma-radiation via a Raf-MEK-ERK-survivin signaling pathway that is independent of cytochrome c release.
Kumar P; Coltas IK; Kumar B; Chepeha DB; Bradford CR; Polverini PJ
Cancer Res; 2007 Feb; 67(3):1193-202. PubMed ID: 17283155
[TBL] [Abstract][Full Text] [Related]
8. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways.
Shen K; Ji L; Gong C; Ma Y; Yang L; Fan Y; Hou M; Wang Z
Biochem Pharmacol; 2012 Sep; 84(6):784-92. PubMed ID: 22771629
[TBL] [Abstract][Full Text] [Related]
9. 20(S)-Protopanaxadiol enhances angiogenesis via HIF-1α-mediated VEGF secretion by activating p70S6 kinase and benefits wound healing in genetically diabetic mice.
Zhang EY; Gao B; Shi HL; Huang LF; Yang L; Wu XJ; Wang ZT
Exp Mol Med; 2017 Oct; 49(10):e387. PubMed ID: 29075038
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic activity of sesamin through the activation of multiple signal pathways.
Chung BH; Lee JJ; Kim JD; Jeoung D; Lee H; Choe J; Ha KS; Kwon YG; Kim YM
Biochem Biophys Res Commun; 2010 Jan; 391(1):254-60. PubMed ID: 19917268
[TBL] [Abstract][Full Text] [Related]
11. Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K/Akt/eNOS signaling.
Namkoong S; Kim CK; Cho YL; Kim JH; Lee H; Ha KS; Choe J; Kim PH; Won MH; Kwon YG; Shim EB; Kim YM
Cell Signal; 2009 Jun; 21(6):906-15. PubMed ID: 19385062
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic action of PPARγ ligand in human umbilical vein endothelial cells is mediated by PTEN upregulation and VEGFR-2 downregulation.
Kim KY; Ahn JH; Cheon HG
Mol Cell Biochem; 2011 Dec; 358(1-2):375-85. PubMed ID: 21769449
[TBL] [Abstract][Full Text] [Related]
14. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells.
Kwon DS; Kwon CH; Kim JH; Woo JS; Jung JS; Kim YK
Eur J Cell Biol; 2006 Nov; 85(11):1189-99. PubMed ID: 16860436
[TBL] [Abstract][Full Text] [Related]
15. TGF-alpha increases human mesenchymal stem cell-secreted VEGF by MEK- and PI3-K- but not JNK- or ERK-dependent mechanisms.
Wang Y; Crisostomo PR; Wang M; Markel TA; Novotny NM; Meldrum DR
Am J Physiol Regul Integr Comp Physiol; 2008 Oct; 295(4):R1115-23. PubMed ID: 18685072
[TBL] [Abstract][Full Text] [Related]
16. Formononetin accelerates wound repair by the regulation of early growth response factor-1 transcription factor through the phosphorylation of the ERK and p38 MAPK pathways.
Huh JE; Nam DW; Baek YH; Kang JW; Park DS; Choi DY; Lee JD
Int Immunopharmacol; 2011 Jan; 11(1):46-54. PubMed ID: 20959155
[TBL] [Abstract][Full Text] [Related]
17. p38 MAPK mediates gamma-irradiation-induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway.
Kumar P; Miller AI; Polverini PJ
J Biol Chem; 2004 Oct; 279(41):43352-60. PubMed ID: 15292252
[TBL] [Abstract][Full Text] [Related]
18. Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.
Sulpice E; Bryckaert M; Lacour J; Contreres JO; Tobelem G
Blood; 2002 Nov; 100(9):3087-94. PubMed ID: 12384403
[TBL] [Abstract][Full Text] [Related]
19. Iron chelation acutely stimulates fetal human intestinal cell production of IL-6 and VEGF while decreasing HGF: the roles of p38, ERK, and JNK MAPK signaling.
Markel TA; Crisostomo PR; Wang M; Herring CM; Lahm T; Meldrum KK; Lillemoe KD; Rescorla FJ; Meldrum DR
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G958-63. PubMed ID: 17204543
[TBL] [Abstract][Full Text] [Related]
20. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
